UK Consultant Endocrinologists needed to share their opinions on echocardiogram use with cabergoline

A recent audit of patients taking cabergoline in NHS Highland revealed variable adherence to echocardiogram screening.  A literature review also conducted highlighted the paucity of data for screening in patients receiving low dose cabergoline [publication under peer review]. 

This short survey is designed to examine clinical practice across the UK, and aims to identify:

- Adherence to current best evidence for echocardiogram surveillance in endocrinologists
- Anticipated acceptance if national guidelines for echocardiogram surveillance were introduced

Make your contribution in identifying if a consensus can be made regarding the use of echocardiograms in cabergoline patients  

Take the survey

Deadline 30 April 2017.